| Three-dimensional structure of human cyclooxygenase (hCOX)-1 M Miciaccia, BD Belviso, M Iaselli, G Cingolani, S Ferorelli, M Cappellari, ... Scientific Reports 11 (1), 4312, 2021 | 59 | 2021 |
| Learning from nature: from a marine natural product to synthetic cyclooxygenase‐1 inhibitors by automated de novo design L Friedrich, G Cingolani, YH Ko, M Iaselli, M Miciaccia, MG Perrone, ... Advanced science 8 (16), 2100832, 2021 | 23 | 2021 |
| Cyclooxygenase inhibition safety and efficacy in inflammation-based psychiatric disorders MG Perrone, A Centonze, M Miciaccia, S Ferorelli, A Scilimati Molecules 25 (22), 5388, 2020 | 21 | 2020 |
| Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection A Scilimati, S Ferorelli, MC Iaselli, M Miciaccia, ML Pati, CG Fortuna, ... European journal of medicinal chemistry 179, 16-25, 2019 | 20 | 2019 |
| Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability ML Pati, P Vitale, S Ferorelli, M Iaselli, M Miciaccia, A Boccarelli, ... European Journal of Medicinal Chemistry 164, 59-76, 2019 | 16 | 2019 |
| An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid MG Perrone, M Miciaccia, P Vitale, S Ferorelli, CCB Araújo, ... European Journal of Medicinal Chemistry 209, 112919, 2021 | 14 | 2021 |
| Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery R Solidoro, A Centonze, M Miciaccia, OM Baldelli, D Armenise, S Ferorelli, ... Medicinal Research Reviews 44 (4), 1800-1866, 2024 | 7 | 2024 |
| Olive mill wastewater fermented with microbial pools as a new potential functional beverage P Foti, PS Occhipinti, N Russo, A Scilimati, M Miciaccia, C Caggia, ... Molecules 28 (2), 646, 2023 | 7 | 2023 |
| The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines A Schirizzi, M Contino, L Carrieri, C Riganti, G De Leonardis, MP Scavo, ... Frontiers in Oncology 13, 1129832, 2023 | 6 | 2023 |
| Fluorochrome selection for imaging intraoperative ovarian cancer probes MG Perrone, P Vitale, M Miciaccia, S Ferorelli, A Centonze, R Solidoro, ... Pharmaceuticals 15 (6), 668, 2022 | 6 | 2022 |
| Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment M Miciaccia, F Rizzo, A Centonze, G Cavallaro, M Contino, D Armenise, ... Pharmaceuticals 17 (1), 135, 2024 | 5 | 2024 |
| m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity D Rocchi, JF González, O Martín-Cámara, MG Perrone, M Miciaccia, ... Molecules 28 (14), 5374, 2023 | 5 | 2023 |
| Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges M Mandorino, A Maitra, D Armenise, OM Baldelli, M Miciaccia, S Ferorelli, ... Cancers 16 (10), 1814, 2024 | 4 | 2024 |
| Patient Bone Marrow Aspiration to Explore the Cyclooxygenases (COXs) Involvement in Multiple Myeloma A Scilimati, M Miciaccia, ML Pati, S Ferorelli, R Giampietro, M Contino, ... J. Cancer Res. Therap. Oncol 9, 1-19, 2021 | 4 | 2021 |
| Effect of microbial fermentation on functional traits and volatiloma profile of pâté olive cake P Foti, CL Randazzo, M Russo, R Di Sanzo, FV Romeo, A Scilimati, ... Food Research International 174, 113510, 2023 | 3 | 2023 |
| A Simplified Direct O2 Consumption-Based Assay to Test COX Inhibition MG Perrone, M Miciaccia, S Ferorelli, A Scilimati Current Enzyme Inhibition 18 (1), 10-18, 2022 | 1 | 2022 |
| Ovine COX-1 Isoenzyme Bio-production M Miciaccia, M Iaselli, S Ferorelli, P Loguercio Polosa, MG Perrone, ... Current Enzyme Inhibition 18 (1), 2-9, 2022 | 1 | 2022 |
| ONC201-Derived Tetrahydropyridopyrimidindiones as Powerful ClpP Protease Activators to Tackle Diffuse Midline Glioma M Miciaccia, OM Baldelli, CG Fortuna, G Cavallaro, D Armenise, A Liturri, ... Journal of Medicinal Chemistry, 2025 | | 2025 |
| KATP Channel Inhibitors Reduce Cell Proliferation Through Upregulation of H3K27ac in Diffuse Intrinsic Pontine Glioma: A Functional Expression Investigation M Antonacci, F Maqoud, A Di Turi, M Miciaccia, MG Perrone, A Scilimati, ... Cancers 17 (3), 358, 2025 | | 2025 |
| The Tyrosine Kinases Inhibitors (TKI) Staurosporine/Midostaurin Act as Cation Channel Inhibitors with Antiproliferative Effects in DIPG36 and DIPG50 Cells M Antonacci, A Di Turi, M Miciaccia, F Maqoud, MG Perrone, A Scilimati, ... The Journal of Pharmacology and Experimental Therapeutics 389, 564, 2024 | | 2024 |
